Daniel Pine, MD

Daniel Pine, MD, is one of the nation’s foremost experts on mood and anxiety disorders. His research has shaped our understanding of how key brain structures such as the amygdala and prefrontal cortex change over time and play critical roles in illness and health. He has also led studies to broaden our knowledge of the biological commonalities and differences among psychiatric disorders in children, adolescents and adults. A leader in the development of diagnostic tools and treatments for childhood psychiatric disorders, Dr. Pine has published hundreds of scientific papers and chaired the Food and Drug Administration’s Psychopharmacology Drug Advisory Board. His many honors include the Blanche Ittelson Award from the American Psychiatric Association for outstanding research contributions to the field of child psychiatry.

Dr. Pine is serving as a member of the Child Mind Institute’s Scientific Research Council in his personal capacity and not as a federal agency representative.

• Food and Drug Administration, Chair of the Psychopharmacologic Drug Advisory Committee
• American Psychiatric Association, Blanche Ittelson Award
• American College of Neuropsychopharmacology, Joel Elkes Award
• NARSAD, Independent Investigator Award
• DSM-V Task Force, Chair of the Developmental Working Group

• University of Chicago, MD in Medicine, 1990
• Grinnell College, BA in Anthropology, 1985